This month’s focus on pharmaphorum is clinical trials, so who better to share their view on global clinical trials than Zheng Su, Editor-in-Chief of the Contemporary Clinical Trials journal.

An experimental drug now in clinical trials as a cancer treatment could help boost the power of first-line tuberculosis (TB) treatments by helping infected cells die a gentler death, Johns Hopkins ...

Listen to more stories on the Noa app. By design, clinical trials ask their participants to take on risk. To develop new vaccines, drugs, or therapies, scientists first have to ask volunteers to ...

Two clinical trials show that it is safe, but more evidence is needed to prove its effectiveness. Read the paper: Phase I/II trial of iPS-cell-derived dopaminergic cells for Parkinson’s disease ...

Last year, the company added clinical trials to the list with the launch of CVS Health Clinical Trial Services, an initiative that works with pharma companies on clinical trial recruitment and ...

A new drug has shown promise in combating Parkinson’s disease while minimizing unwanted side effects. The once-daily pill, tavapadon, was found to relieve symptoms — including stiffness ...

This creates a challenge for clinical trials. Juan M. Pericàs, MD, MPH, PhD Juan M. Pericàs, MD, MPH, PhD, team leader of the Liver, Metabolism and Infection group at Vall d’Hebron University ...

"Our partnership with Recursion underscores the transformative potential of real-world data in driving smarter clinical trials," said Andrew Kress, CEO of HealthVerity. "By providing seamless ...

Another keynote panel with industry leaders from AstraZeneca, ICON, and Eilean Therapeutics will investigate the future of clinical trials with a spotlight on enhancing patient centricity ...

A new drug has shown promise in combating Parkinson’s disease while minimizing unwanted side effects. The once-daily pill, tavapadon, was found to relieve symptoms — including stiffness ...